Indian Journal of Dermatology
  Publication of IADVL, WB
  Official organ of AADV
Indexed with Science Citation Index (E) , Web of Science and PubMed
Users online: 2604  
Home About  Editorial Board  Current Issue Archives Online Early Coming Soon Guidelines Subscriptions  e-Alerts    Login  
    Small font sizeDefault font sizeIncrease font size Print this page Email this page

Table of Contents 
Year : 2016  |  Volume : 61  |  Issue : 1  |  Page : 99-100
Dermatology life quality index does not reflect quality of life status of Indian vitiligo patients

Institute of Applied Dermatology, Kasaragod, Kerala, India

Date of Web Publication15-Jan-2016

Correspondence Address:
S R Narahari
Institute of Applied Dermatology, Kasaragod, Kerala
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0019-5154.174048

Rights and Permissions

How to cite this article:
Narahari S R, Prasanna K S, Aggithaya M G, Bose K S, Praseeda T R. Dermatology life quality index does not reflect quality of life status of Indian vitiligo patients. Indian J Dermatol 2016;61:99-100

How to cite this URL:
Narahari S R, Prasanna K S, Aggithaya M G, Bose K S, Praseeda T R. Dermatology life quality index does not reflect quality of life status of Indian vitiligo patients. Indian J Dermatol [serial online] 2016 [cited 2023 Mar 22];61:99-100. Available from:


There are many tools to measure quality of life (QoL) changes in vitiligo patients. Dermatology-specific tools include Dermatology Life Quality Index (DLQI) and three others. [1] DLQI is frequently used to measure changes in QoL of vitiligo patients in darker skinned races. [2] Finlay and his department reviewed the international use of DLQI. We explored its usefulness in Indian vitiligo patients. Hundred and eighty-seven patients were recruited for the study during 2012-2014. Institutional Ethics Committee gave ethical approval and informed consent taken from all patients. Ninety-six patients were allocated based on random numbers for DLQI based QoL assessment. A power point slides presentation was prepared to assist counseling of these patients. Counseling framework included details about the disease/associated diseases, treatment options available in biomedicine and other Indian systems of medicine, diet/investigations and the importance of medication adherence, and prognostic factors of the disease. No promise is made on nonrecurrence when re-pigmented. Nurse administered the DLQI before doctor's consultation. Three languages were used such as Malayalam, Kannada, and English.

Raw data from DLQI score sheets are tabulated on excel sheet. SPSS 16 (SPSS Inc., Chicago, IL) was used for analyses. Analysis of variance test was used for comparing the effect of gender, age, religion, education, and duration of the disease. Correlation analysis was done for body area involvement and psychological issues. DLQI scores revealed that in 5.2% of patients vitiligo had no effect at all on patient's life, 49% of patients had small effect on QoL, moderate effect on patient's life (29.2%), very large effect on patient's life (16.7%), and extremely large effect (0%). There was no significant effect of disease based on DLQI scoring. There was no influence of gender, age, education, religion, body area involvement, psychological factors (as narrated in DLQI), and other parameters [Table 1]. However, self-esteem, body image, stigma, and anxiety influenced health-related QoL in many other studies. [1]

Our patients had other complaints: Restlessness, fears of various objects and situations, suicidal tendency, etc. Other worries of patients included marriage prospects, teasing students in odd names in schools, questioning by others, etc.
Table 1: Mean DLQI scores of patient characteristics

Click here to view

However, DLQI showed small or no effect on QoL of 54% of patients. Indian dermatologists notice that patients are dreaded by the disease. There were multiple disease-specific QoL scales, Vitiligo Impact Scale (VIS), [3] VIS-22, [4] and vitiligo-specific QoL instrument. [5] VIS and VIS-22 developed in India, but its reproducibility on culture specific psychosocial changes in Indian population is unknown. VitiQoL is found reliable in the USA and Brazilian patients, but no studies were done in Indian patients. We need a culture-specific questionnaire reflecting Indian situations.

Financial support and sponsorship


Conflicts of interest

There are no conflicts of interest.

   References Top

Sangma LN, Nath J, Bhagabati D. Quality of life and psychological morbidity in vitiligo patients: A study in a teaching hospital from North-East India. Indian J Dermatol 2015;60:142-6.  Back to cited text no. 1
[PUBMED]  Medknow Journal  
Basra MK, Fenech R, Gatt RM, Salek MS, Finlay AY. The dermatology life quality index 1994-2007: A comprehensive review of validation data and clinical results. Br J Dermatol 2008;159:997-1035.  Back to cited text no. 2
Krishna GS, Ramam M, Mehta M, Sreenivas V, Sharma VK, Khandpur S. Vitiligo impact scale: An instrument to assess the psychosocial burden of vitiligo. Indian J Dermatol Venereol Leprol 2013;79:205-10.  Back to cited text no. 3
[PUBMED]  Medknow Journal  
Gupta V, Sreenivas V, Mehta M, Khaitan BK, Ramam M. Measurement properties of the vitiligo impact scale-22 (VIS-22), a vitiligo-specific quality-of-life instrument. Br J Dermatol 2014;171:1084-90.  Back to cited text no. 4
Lilly E, Lu PD, Borovicka JH, Victorson D, Kwasny MJ, West DP, et al. Development and validation of a vitiligo-specific quality-of-life instrument (VitiQoL). J Am Acad Dermatol 2013;69:e11-8.  Back to cited text no. 5


  [Table 1]

This article has been cited by
1 The humanistic burden of vitiligo: a systematic literature review of quality-of-life outcomes
M. Picardo, R.H. Huggins, H. Jones, R. Marino, M. Ogunsola, J. Seneschal
Journal of the European Academy of Dermatology and Venereology. 2022;
[Pubmed] | [DOI]
2 Quality of life measurement in vitiligo. Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes with external experts
Pavel V. Chernyshov, Lucia Tomas-Aragones, Liana Manolache, Nives Pustisek, Carmen Maria Salavastru, Servando E. Marron, Anthony Bewley, Ake Svensson, Françoise Poot, Alina Suru, Sam S. Salek, Matthias Augustin, Jacek ?. Szepietowski, Dimitra Koumaki, Alexander C. Katoulis, Francesca Sampogna, Damiano Abeni, Dennis Michael Linder, Reinhart Speeckaert, Nanja van Geel, Julien Seneschal, Khaled Ezzedine, Andrew Y. Finlay
Journal of the European Academy of Dermatology and Venereology. 2022;
[Pubmed] | [DOI]
3 Strengthen the Indian dermatology services using dermatology nursing
Laxmi V Nair, SR Narahari, US Reethadevi
Indian Journal of Dermatology, Venereology and Leprology. 2022; 88: 706
[Pubmed] | [DOI]
4 Quality of life impairment amongst persons living with vitiligo using disease specific vitiligo quality of life index: A Nigerian perspective
Umar Abdullahi, TahirTuraki Mohammed, BolanleO P. Musa
Nigerian Postgraduate Medical Journal. 2021; 28(3): 169
[Pubmed] | [DOI]


Print this article  Email this article
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Article in PDF (252 KB)
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
* Registration required (free)  

    Article Tables

 Article Access Statistics
    PDF Downloaded65    
    Comments [Add]    
    Cited by others 4    

Recommend this journal